Fig. 1From: Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trialDiagram of the study design. CAL, coronary artery lesion; CRP, C-reactive protein; IVIG, intravenous immunoglobulin; KD, Kawasaki diseaseBack to article page